PrecisionLife and Sano Genetics announce partnership to accelerate understanding of long COVID and help identify new treatments
A new partnership between PrecisionLife and Sano Genetics will help advance researchers’ understanding of the drivers of long COVID,…
11/05/22
PrecisionLife announces appointment of Colin Stubberfield as SVP Drug Discovery to lead development of its precision medicine programs
PrecisionLife announces the appointment of Colin Stubberfield, Ph.D. as SVP Drug Discovery.
21/02/22
PrecisionLife announces first close of Series A financing to progress its drug discovery pipeline and commercial partnerships
OXFORD, UK January 31, 2022 – PrecisionLife announces the first close of its Series A investment round.
31/01/22
UK BioIndustry Association launches first TechBio company report
OXFORD, UK: PrecisionLife featured as a case study of how a data-driven techbio company is transforming drug discovery and…
15/10/21
Best Chronic Disease Biology Company 2021 awarded to PrecisionLife
OXFORD, UK The International Life Sciences Awards has named PrecisionLife as the Best Chronic Disease Biology R&D Company 2021.
20/09/21
Ray Pawlicki, Previously CIO at Biogen and Novartis, Joins PrecisionLife as Executive Chair to Accelerate Strategic Expansion
OXFORD, UK June 24th, 2021 –
24/06/21
PrecisionLife and Cyclica sign strategic partnership combining leading data-driven biology and chemistry platforms to create a rapid innovation engine for drug discovery
OXFORD and TORONTO, May 17th, 2021
17/05/21
PrecisionLife unveils new spin-out Synomics taking its proven analytics platform into animal and crop health sectors
OXFORD, UK, April 7, 2021 PrecisionLife Ltd, leaders in combinatorial analytics, today unveils the launch of its new spin-out…
7/04/21
PrecisionLife continues growth and expansion with acquisition of Danish genomic analytics innovator GenoKey
OXFORD, UK, and AALBORG, Denmark, March 24, 2021
24/03/21
PrecisionLife joins Nvidia Inception – the premier program for AI and data science startups
PrecisionLife will benefit from Nvidia’s Inception program that supports AI companies from “seed to unicorn” status providing the company…
15/03/21
New partnership targets effective precision medicine treatments for respiratory patients
BREATHE – the Health Data Research Hub for Respiratory Health (‘BREATHE’) partners with PrecisionLife to expand understanding of respiratory…
12/03/21
PrecisionLife joins EU endometriosis precision medicine consortium
Oxford, UK – PrecisionLife is part of a new £5.3m EU Horizon 2020 project that aims to develop precision…
3/02/21
PrecisionLife joins Genomics England’s Discovery Forum
Oxford, UK – PrecisionLife is now a member of Genomics England’s Discovery Forum, a network of organisations focused on…
2/11/20
PrecisionLife identified as leaders in fight against COVID-19 by Barclays Private Bank
Oxford, UK – PrecisionLife has been identified as a leader in the ongoing fight against COVID-19 by Barclays Private…
30/10/20
Simon Beaulah joins PrecisionLife as SVP of Healthcare & Head of US Operations
Oxford, UK – PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment…
9/09/20
Digital RESI event
Oxford, UK – We’ll be joining startups, technology partners and global investors at digital ‘Redefining Early Stage Investments’ (RESI)…
27/07/20
PrecisionLife CEO speaks to the 20/15 Visioneers Rock Stars podcast
Oxford, UK – PrecisionLife CEO Dr Steve Gardner was a guest on the thoroughly entertaining 20/15 Visioneers podcast last…
17/07/20
PrecisionLife present at One Nucleus’ ON Helix event
Oxford, UK – Find out a little more about PrecisionLife at the digital ON Helix 20 event next week…
14/07/20